Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New oral drug trial targets Hard-to-Treat cancers with specific genetic flaw

NCT ID NCT06810544

Summary

This early-stage clinical trial is testing a new oral drug called TNG456, both alone and combined with another cancer drug (abemaciclib), in patients with advanced solid tumors that have a specific genetic change called MTAP loss. The study aims to find safe doses and see if the treatment can shrink tumors in cancers like lung cancer, brain tumors, and others. About 191 adults who have tried standard treatments without success may participate and can continue treatment as long as it helps control their cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Dana Farber Cancer Institute

    RECRUITING

    Boston, Massachusetts, 02215, United States

    Contact

  • MD Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

    Contact

  • Mayo Clinic Cancer Center

    RECRUITING

    Rochester, Minnesota, 55905-0001, United States

    Contact

  • Mayo Clinic Jacksonville

    RECRUITING

    Jacksonville, Florida, 32224, United States

    Contact

  • Mayo Clinic Scottsdale

    RECRUITING

    Scottsdale, Arizona, 85259-5452, United States

    Contact

  • Memorial Sloan Kettering Cancer Center

    RECRUITING

    New York, New York, 11065, United States

    Contact

  • NEXT Virginia

    RECRUITING

    Fairfax, Virginia, 22031, United States

    Contact

  • NYU Langone Health

    RECRUITING

    New York, New York, 10016, United States

    Contact

  • Northwestern Memorial Hospital

    RECRUITING

    Chicago, Illinois, 60611-2908, United States

    Contact

  • Ohio State University Comprehensive Cancer Center

    RECRUITING

    Columbus, Ohio, 43210, United States

    Contact

  • Sibley Memorial Hospital

    RECRUITING

    Washington D.C., District of Columbia, 20016, United States

    Contact

  • University of California, Irvine

    RECRUITING

    Irvine, California, 92686, United States

    Contact

  • University of Utah, Huntsman Cancer Institute

    RECRUITING

    Salt Lake City, Utah, 84112-5500, United States

    Contact

Conditions

Explore the condition pages connected to this study.